about
Biomarker-based trials in neuro-oncologyDesigning a definitive trial for adjuvant targeted therapy in genotype defined lung cancer: the ALCHEMIST trialsLung-MAP--framework, overview, and design principlesThe FOCUS4 design for biomarker stratified trialsThe ALTERNATE trial: assessing a biomarker driven strategy for the treatment of post-menopausal women with ER+/Her2- invasive breast cancerAn overview of the design and conduct of the BATTLE trialsDesign and statistical principles of the SHIVA trialAn overview of the NCI precision medicine trials-NCI MATCH and MPACTMolecular and clinical implementations of ovarian cancer mouse avatar modelsStatistical principles for omics-based clinical trialsMantle cell lymphoma-management in evolutionStaging and response assessment in lymphomas: the new Lugano classificationExpert consensus on image-guided radiofrequency ablation of pulmonary tumors--2015 editionPrognostic scores for brain metastasis patients: use in clinical practice and trial designTargeted therapy in non-small cell lung cancer: a focus on epidermal growth factor receptor mutationsMethodology of clinical trials in lung cancerChemoradiotherapy for stage III non-small cell lung cancer: have we reached the limit?Extended resection of non-small cell lung cancer invading the left atrium, is it worth the risk?Neoadjuvant chemoradiotherapy followed by surgery for stage IIIa and IIIb non-small-cell lung cancer (NSCLC): is it still justified?Stereotactic ablative body radiotherapy (SABR): an alternative to surgery in stage I-II non-small-cell cancer of the lung?Upcoming innovations in lung cancer immunotherapy: focus on immune checkpoint inhibitorsRisk- and response-adapted strategies for the management of Hodgkin lymphomaFindings from the Adjuvant Colon Cancer End Points (ACCENT) Collaborative Group: the power of pooled individual patient data from multiple clinical trials.Gallbladder cancer: South American experience.Biliary tract cancers: epidemiology, molecular pathogenesis and genetic risk associations.Organizing a breast cancer database: data management.From genomic data analysis to drug development: a new generation of trials using molecular marker assessment in breast cance.On independent data monitoring committees in oncology clinical trials.Prof. Peter Yu: opportunities and challenges in big data era.The emerging role of advanced neuroimaging techniques for brain metastases.Professor Charles M. Balch: higher sophistication and accuracy of clean data are important for sophisticated clinical trials.Proton therapy for tumors of the base of the skull.Drug designs fulfilling the requirements of clinical trials aiming at personalizing medicine.Genotyping of cutaneous melanoma.Treatment of KIT-mutated metastatic mucosal melanoma.Treatment algorithm of metastatic mucosal melanoma.Adaptive clinical trial designs in oncology.Mining the ACCENT database: a review and updatePrevention of colorectal cancer and dietary managementCauses and management of early colorectal cancer.
P1433
Q26786686-762E8B2B-66E3-4FF5-B38C-DB2CA458E760Q26786691-8ECD1A9E-ED27-4B86-9E4B-F08010071903Q26786694-789FDE55-CE77-4925-B0A0-FF51EB46FEBFQ26786700-228BB8FC-0D67-4A2B-A523-13144B934C7EQ26786704-55C62E5C-F244-4593-B7C2-FF6B1EEEC325Q26786709-FC845ECC-DD84-4DD6-9D34-31EAEF91DAEBQ26786712-6EE41E71-5AAC-43D1-8831-4E0F38A12CA1Q26786719-A53E901E-8525-4A27-9849-717ED81F6F2AQ26786724-FDCB65D1-9030-47B9-9608-E57389875900Q26786730-4DB6FEB3-B6BB-4549-A04B-575D342AEC7AQ26823582-E3D0BB9A-4A18-41F1-BE98-E75EB5A4A8D9Q26823706-FA5F42B5-4A3A-486C-9538-BA406D1309FDQ26995386-B5C9EC9B-8BE2-450E-BDD3-8AFEDBE72C4DQ27003255-587F7FD1-BC32-4A66-80AD-337B4146FC17Q28070099-43A16D36-8D67-43B9-8408-2102648CAE33Q28071367-9BDC0889-D58F-450E-8F7D-6B79ACF3CF4AQ28071462-1796DD83-1FDE-4180-A246-5F30DFD87182Q28072905-E4834B5F-933A-445D-9947-9DB2DD8EB9DBQ28074601-A0C5B048-D3A9-4663-8D5A-2D71E856BD21Q28078487-C1EC14E3-C58D-419C-BDAC-BACF79941796Q28078937-FF69FB5C-BE24-44C0-8E50-FEC9AF6831BEQ28082818-A53B00EA-D9A7-40C9-B748-E4A4DADBE446Q30239796-7CAF4F04-78C5-4140-BD75-4C75073AEF45Q30241557-14236478-F841-4013-AF37-957C765C1C4FQ30241563-B4F72E1E-FD55-4647-9A23-E0AE67E83DCBQ30388275-1BF4EC7E-4A52-44C3-B5A4-A032F17B9A7CQ30923203-82550037-E025-4E8A-9E19-4676291B0EF2Q30923220-720E183D-DAD1-4E34-8B9F-5BC860E9A7D5Q30923498-197E6FC0-1388-4755-8B55-6C67016DDF9AQ30976821-A33CB87E-33F7-4C85-8B73-5BC935C7F064Q31153321-5D43ABBF-90A2-4A49-8F79-8ED1E7F8158EQ33276183-59D2AECB-2F34-4EF7-9526-1E7A5BEA093FQ34535243-F612DFB0-5F3C-4924-AC8B-972E00D63431Q34667738-D0C3B90A-5E95-45D2-9972-5DA6A3F039B2Q34669154-C8672FA7-60E8-404C-910C-490675471283Q34669160-30B30B3F-E733-47DC-B765-08B99E8AE90EQ35206844-CFCE3944-8EDD-4AF4-846C-D8C193777EE0Q35530394-6E995141-E475-4C07-BC5C-1F36B313D62AQ35557470-23C099F9-4287-42C9-B3E0-1F3F1774A309Q35595118-8266B8D2-838A-4BE0-9531-3A9F47923F5D
P1433
description
czasopismo naukowe
@pl
journal
@en
revista científica
@es
wetenschappelijk tijdschrift
@nl
wissenschaftliche Fachzeitschrift
@de
name
Chinese clinical oncology
@ast
Chinese clinical oncology
@en
Chinese clinical oncology
@es
Chinese clinical oncology
@nl
type
label
Chinese clinical oncology
@ast
Chinese clinical oncology
@en
Chinese clinical oncology
@es
Chinese clinical oncology
@nl
altLabel
Chin Clin Oncol
@en
prefLabel
Chinese clinical oncology
@ast
Chinese clinical oncology
@en
Chinese clinical oncology
@es
Chinese clinical oncology
@nl
P3181
P1055
P1156
21100448930
P1476
Chinese clinical oncology
@en